Neonatal Intensive Care Centre, St. George's University Hospitals NHS Foundation Trust, London, United Kingdom.
St George's University of London, London, United Kingdom.
Am J Perinatol. 2024 May;41(S 01):e2674-e2678. doi: 10.1055/a-2142-9434. Epub 2023 Jul 27.
This study aimed to compare outcomes of infants who received less invasive surfactant administration (LISA) in the delivery suite (LISA-DS) with those who received LISA on the neonatal unit (LISA-NNU).
A prospective cohort study was undertaken of all infants who received LISA in a single center. Clinical outcomes included admission temperature, the need for intubation, durations of invasive and noninvasive ventilation, length of hospital stay and the incidences of bronchopulmonary dysplasia (BPD), intraventricular hemorrhage (IVH), retinopathy of prematurity (ROP), and requirement for home oxygen were compared between the two groups as were complications of the procedure.
The 54 LISA-DS infants had similar gestational ages and birth weights to the 26 LISA-NNU infants ( = 0.732, 0.928, respectively). There were no significant differences between the admission temperatures (median [range]: 36.8 [36-38.7] vs. 36.8°C [36.4-37.7]; = 0.451) or need for intubation in less than 72 hours of birth (28 vs. 23%, = 0.656). The durations of invasive ventilation (median: 2 [0-65] vs. 1 [0-35] days; = 0.188) and noninvasive ventilation (median: 37 [24-81] vs. 37 [3-225] days; = 0.188) and the incidences of BPD ( = 0.818), IVH ( = 0.106), ROP ( = 0.526), and home oxygen requirement ( = 0.764) were similar. The percentage of successful first attempts with LISA (63 vs. 70%, = 0.816) or associated with hypoxia episodes (32 vs. 42%, = 0.194) did not differ significantly by site of administration.
The outcomes of LISA performed on the DS were similar to those of LISA performed on the NNU.
· Prematurely born infants who received LISA in the DS had comparable clinical outcomes to infants who received LISA on NNU.. · No significant differences in admission temperature was noticed in infants who received LISA, in DS versus NNU..
本研究旨在比较在产房(LISA-DS)接受微创表面活性剂给药(LISA)的婴儿与在新生儿重症监护病房(LISA-NNU)接受 LISA 的婴儿的结局。
对在单中心接受 LISA 的所有婴儿进行前瞻性队列研究。临床结局包括入院体温、插管需求、有创和无创通气持续时间、住院时间以及支气管肺发育不良(BPD)、脑室内出血(IVH)、早产儿视网膜病变(ROP)和家庭氧疗需求的发生率,并比较两组之间的程序并发症。
54 例 LISA-DS 婴儿的胎龄和出生体重与 26 例 LISA-NNU 婴儿相似(=0.732,0.928)。入院体温(中位数[范围]:36.8 [36-38.7] vs. 36.8°C [36.4-37.7];=0.451)或出生后 72 小时内插管的需求(28 比 23%,=0.656)均无显著差异。有创通气(中位数:2 [0-65] vs. 1 [0-35] 天;=0.188)和无创通气(中位数:37 [24-81] vs. 37 [3-225] 天;=0.188)的持续时间以及 BPD(=0.818)、IVH(=0.106)、ROP(=0.526)和家庭氧疗需求(=0.764)的发生率相似。LISA 首次尝试成功率(63 比 70%,=0.816)或与缺氧发作相关(32 比 42%,=0.194)的比例在不同的给药部位之间无显著差异。
在产房进行 LISA 的结果与在新生儿重症监护病房进行 LISA 的结果相似。
· 在产房接受 LISA 的早产儿的临床结局与在新生儿重症监护病房接受 LISA 的婴儿相似。· 在接受 LISA 的婴儿中,在产房和新生儿重症监护病房之间,入院体温无显著差异。